Literature DB >> 8250988

Incidence of rheumatoid arthritis in central Massachusetts.

K W Chan1, D T Felson, R A Yood, A M Walker.   

Abstract

OBJECTIVE: To determine whether there is a secular decline in the incidence of rheumatoid arthritis (RA), as has been suggested by previous studies.
METHODS: In the absence of comprehensive data in the United States population, we estimated RA incidence in a health maintenance organization population from 1987 through 1990 and compared the rates with those in an earlier, similarly performed study from Rochester, Minnesota, which covered the years 1950 through 1974. RA estimates were based on our review of medical records of patients who had been diagnosed as having RA or related diseases during the period of January 1, 1987 through December 31, 1990.
RESULTS: Annual age-standardized incidence of classic or definite RA (according to the American College of Rheumatology [formerly, the American Rheumatism Association] 1958 criteria) in patients aged 18 or older was 22 per 100,000 in men and 60 per 100,000 in women. The incidence of RA increased with age, with a marked increase in women older than 50.
CONCLUSION: We found no secular change in RA incidence compared with the similarly ascertained historical data.

Entities:  

Mesh:

Year:  1993        PMID: 8250988     DOI: 10.1002/art.1780361207

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  12 in total

1.  Incidence of rheumatoid arthritis from 1995 to 2001: impact of ascertainment from multiple sources.

Authors:  Jens K Pedersen; Niels K Kjaer; Anders J Svendsen; Kim Hørslev-Petersen
Journal:  Rheumatol Int       Date:  2008-10-14       Impact factor: 2.631

2.  Genetic linkage of familial granulomatous inflammatory arthritis, skin rash, and uveitis to chromosome 16.

Authors:  G Tromp; H Kuivaniemi; S Raphael; L Ala-Kokko; A Christiano; E Considine; R Dhulipala; J Hyland; A Jokinen; S Kivirikko; R Korn; S Madhatheri; S McCarron; L Pulkkinen; H Punnett; K Shimoya; L Spotila; A Tate; C J Williams
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

3.  Refinement of the chromosome 5p locus for familial calcium pyrophosphate dihydrate deposition disease.

Authors:  L J Andrew; V Brancolini; L S de la Pena; M Devoto; F Caeiro; R Marchegiani; A Reginato; A Gaucher; P Netter; P Gillet; D Loeuille; D J Prockop; A Carr; B F Wordsworth; M Lathrop; S Butcher; E Considine; K Everts; A Nicod; S Walsh; C J Williams
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

4.  Changes in the incidence and prevalence of rheumatoid arthritis in Kamitonda, Wakayama, Japan, 1965-1996.

Authors:  K Shichikawa; K Inoue; S Hirota; A Maeda; H Ota; M Kimura; T Ushiyama; M Tsujimoto
Journal:  Ann Rheum Dis       Date:  1999-12       Impact factor: 19.103

5.  Incidence of rheumatoid arthritis in Finland during 1980-1990.

Authors:  O Kaipiainen-Seppänen; K Aho; H Isomäki; M Laakso
Journal:  Ann Rheum Dis       Date:  1996-09       Impact factor: 19.103

Review 6.  Optimising low-dose methotrexate for rheumatoid arthritis-A review.

Authors:  Catherine J Lucas; Simon B Dimmitt; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2019-08-09       Impact factor: 4.335

7.  Annual incidence of inflammatory joint diseases in a population based study in southern Sweden.

Authors:  M K Söderlin; O Börjesson; H Kautiainen; T Skogh; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

8.  Early rheumatoid arthritis in Italy: study of incidence based on a two-level strategy in a sub-area of Florence (Scandicci-Le Signe).

Authors:  Maurizio Benucci; Emanuela Cammelli; Mariangela Manfredi; Gianantonio Saviola; Paola Baiardi; Alessandro Mannoni
Journal:  Rheumatol Int       Date:  2008-01-30       Impact factor: 2.631

Review 9.  Is rheumatoid arthritis disappearing?

Authors:  T Uhlig; T K Kvien
Journal:  Ann Rheum Dis       Date:  2004-07-29       Impact factor: 19.103

Review 10.  Epidemiology and burden of illness of rheumatoid arthritis.

Authors:  Tore K Kvien
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.